Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
ITC: SELECT trial: Lenvatinib effects similar regardless of site, number of metastases
Outcomes in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib did not differ based on metastatic site,...
News
Study finds no link between thyroid autoimmunity, breast cancer outcomes
In contrast with at least two prior small studies, thyroid peroxidase autoantibodies were not associated with breast cancer outcomes in a large...
News
Obesity linked with more aggressive papillary thyroid carcinoma
Obesity was strongly associated with more aggressive papillary thyroid carcinoma features, but not with a greater likelihood of disease recurrence...
News
TCT: Differing sirolimus absorption rates, similar outcomes in PANDA III
Two sirolimus-eluting stents with differing elution an absorption kinetics were equally effective in the prospective, randomized PANDA III trial...
News
TCT: Everolimus stents best paclitaxel for diabetes patients
Everolimus-eluting stents were shown to be superior to paclitaxel-eluting stents in diabetes patients with CAD who underwent PCI in the randomized...
News
CML outcomes in the age of TKIs
Major molecular response rates at 12 months were better among CML patients treated with dasatinib/nilotinib vs. imatinib for first-line therapy,...
News
TCT: CTO treatment after MI doesn’t benefit LV function
Recanalization of a chronic total occlusion in a noninfarct-related artery within a week after primary percutaneous coronary intervention was safe...
News
TCT: No difference at 2 years between Absorb BVS and XIENCE
Two-year clinical outcomes did not differ significantly between patients treated with the Absorb everolimus-eluting bioresorbable vascular...
News
CML: Select TKI based on comorbidities, monitor toxicity and adherence
CML treatment success is contingent on managing reversible early toxicity, adherence to therapy, achieving landmarks of response, and remaining...
News
TCT: FFR-CT improved costs, quality of life in PLATFORM trial
Estimating fractional flow reserve with computed tomography reduced resource use and costs when compared with invasive coronary angiography in...
News
Hemorrhage control after pelvic fracture: Methods vary widely
Methods for controlling hemorrhage from severe pelvic fractures vary widely across institutions, according to findings from a prospective...
News
TCT: Absorbable metal scaffold performs well in BIOSOLVE II
Implantation of the novel DREAMS 2G sirolimus-eluting absorbable metal scaffold in patients with de novo coronary lesions was feasible and had...
News
Baseline factors predict early response to multiple myeloma therapy
Greater absolute free light chain difference, age less than 75 years, hemoglobin concentration, and IgA heavy chain secretion predict early...
News
Power morcellation risks increase with age
Laparoscopic hysterectomy provides better overall outcomes than either laparoscopic hysterectomy with electric power morcellation or abdominal...
News
BCVI: Screen with CT angiography, confirm with DSA
Blunt cerebrovascular injuries should be assessed using 64-channel computed tomographic angiography screening and verified with digital...